Cytomegalovirus DNAemia developed in @ ( @ % ) of @ patients in the valacyclovir group and @ ( @ % ) of @ patients in the valganciclovir group ( adjusted hazard ratio , @ ; @ % confidence interval , @ to @ ; P = @ ) .